MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
Open | $4.170 |
Close | - |
Volume / Avg. | 639.191K / 2.852M |
Day Range | 4.120 - 4.210 |
52 Wk Range | 3.170 - 5.750 |
Market Cap | $1.143B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 11.5% |
Days to Cover | 10.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MannKind (NASDAQ: MNKD) through any online brokerage.
Other companies in MannKind’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
The latest price target for MannKind (NASDAQ: MNKD) was reported by Cantor Fitzgerald on Friday, March 15, 2024. The analyst firm set a price target for 6.50 expecting MNKD to rise to within 12 months (a possible 54.03% upside). 7 analyst firms have reported ratings in the last year.
The stock price for MannKind (NASDAQ: MNKD) is $4.22 last updated April 24, 2024 at 5:24 PM EDT.
There are no upcoming dividends for MannKind.
MannKind’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.